MedTrace Logo

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism

NCT04100863 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-06-05

No results posted yet for this study

Summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding autism.

Conditions

  • Autism
  • Autism Spectrum Disorder
  • Autistic Disorder
  • Autism, Akinetic
  • Autism; Atypical
  • Autism; Psychopathy
  • Autism Fragile Syndrome X
  • Autism With High Cognitive Abilities
  • Autism-Related Speech Delay
  • Autism, Susceptibility to, 6
  • Autism Spectrum Disorder High-Functioning
  • Autistic Thinking
  • Autism, Susceptibility to, X-Linked 6
  • Autistic Behavior

Interventions

OTHER

No Intervention

There is no intervention for this study.

Sponsors & Collaborators

  • ProgenaBiome

    lead OTHER

Principal Investigators

  • Sabine Hazan, MD · ProgenaBiome

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2030-03-31
Completion
2030-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04100863 on ClinicalTrials.gov